Literature DB >> 10866283

Increased repair and cell survival in cells treated with DIR1 antisense oligonucleotides: implications for induced radioresistance.

T Robson1, M E Price, M L Moore, M C Joiner, V J McKelvey-Martin, S R McKeown, D G Hirst.   

Abstract

PURPOSE: To determine whether repression of a recently isolated, X-ray-responsive gene, DIR1, using antisense oligonucleotides could affect clonogenic cell survival and repair of DNA strand breaks and have a possible role in the mechanism underlying the phenomenon of 'induced radioresistance' (IRR).
MATERIALS AND METHODS: Three cell lines, V79, RT112 and UM-UC-3, which are known to exhibit low-dose hypersensitivity (HRS) and induced radioresistance (IRR), and the radiosensitive cell line ATBIVA, were transfected with antisense oligonucleotides directed towards the DIR1 gene. Scrambled oligonucleotides were used as controls. DNA single-strand break (ssb) repair, using the alkaline comet assay, and cell survival using a standard clonogenic assay was measured after exposure to X-rays.
RESULTS: Following treatment with 4Gy X-rays, the V79, RT112 and UM-UC-3 cell lines all exhibited significantly increased rates of ssb repair after transfection with DIR1 antisense oligonucleotides compared with cells transfected with scrambled oligonucleotides. They also demonstrated significantly enhanced survival after exposure to 2 Gy X-rays; the radiosensitive ATBIVA cells did not show these effects.
CONCLUSIONS: Repression of the DIR1 gene product leads to an increase in the rate of repair and cell survival in three radioresistant cells lines but not in the radiosensitive ATBIVA cell line. Because DIR1 is repressed by X-rays in the dose range where IRR is observed, it may represent a candidate gene involved in the IRR phenomenon.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10866283     DOI: 10.1080/095530000138277

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  10 in total

Review 1.  ATM-NF-kappaB connection as a target for tumor radiosensitization.

Authors:  Kazi Mokim Ahmed; Jian Jian Li
Journal:  Curr Cancer Drug Targets       Date:  2007-06       Impact factor: 3.428

Review 2.  NF-kappa B-mediated adaptive resistance to ionizing radiation.

Authors:  Kazi Mokim Ahmed; Jian Jian Li
Journal:  Free Radic Biol Med       Date:  2007-10-10       Impact factor: 7.376

Review 3.  Cell cycle regulators guide mitochondrial activity in radiation-induced adaptive response.

Authors:  Aris T Alexandrou; Jian Jian Li
Journal:  Antioxid Redox Signal       Date:  2014-02-14       Impact factor: 8.401

4.  FKBPL and peptide derivatives: novel biological agents that inhibit angiogenesis by a CD44-dependent mechanism.

Authors:  Andrea Valentine; Martin O'Rourke; Anita Yakkundi; Jenny Worthington; Michelle Hookham; Roy Bicknell; Helen O McCarthy; Keeva McClelland; Lynn McCallum; Hayder Dyer; Hayley McKeen; David J J Waugh; Jennifer Roberts; Joanne McGregor; Graham Cotton; Iain James; Timothy Harrison; David G Hirst; Tracy Robson
Journal:  Clin Cancer Res       Date:  2011-03-01       Impact factor: 12.531

Review 5.  Breast cancer adaptive resistance: HER2 and cancer stem cell repopulation in a heterogeneous tumor society.

Authors:  Nadire Duru; Demet Candas; Guochun Jiang; Jian Jian Li
Journal:  J Cancer Res Clin Oncol       Date:  2013-08-30       Impact factor: 4.553

Review 6.  Bringing the heavy: carbon ion therapy in the radiobiological and clinical context.

Authors:  Cody D Schlaff; Andra Krauze; Arnaud Belard; John J O'Connell; Kevin A Camphausen
Journal:  Radiat Oncol       Date:  2014-03-28       Impact factor: 3.481

7.  Non-induction of radioadaptive response in zebrafish embryos by neutrons.

Authors:  Candy Y P Ng; Eva Y Kong; Alisa Kobayashi; Noriyoshi Suya; Yukio Uchihori; Shuk Han Cheng; Teruaki Konishi; Kwan Ngok Yu
Journal:  J Radiat Res       Date:  2016-02-04       Impact factor: 2.724

8.  FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer.

Authors:  Stephanie Annett; Gillian Moore; Amy Short; Andrea Marshall; Cian McCrudden; Anita Yakkundi; Sudipto Das; W Glenn McCluggage; Laura Nelson; Ian Harley; Nermeen Moustafa; Catherine J Kennedy; Anna deFazio; Alison Brand; Raghwa Sharma; Donal Brennan; Sharon O'Toole; John O'Leary; Mark Bates; Ciarán O'Riain; Darran O'Connor; Fiona Furlong; Helen McCarthy; Adrien Kissenpfennig; Lana McClements; Tracy Robson
Journal:  Br J Cancer       Date:  2019-11-27       Impact factor: 9.075

9.  The anti-migratory effects of FKBPL and its peptide derivative, AD-01: regulation of CD44 and the cytoskeletal pathway.

Authors:  Anita Yakkundi; Lynn McCallum; Anthony O'Kane; Hayder Dyer; Jenny Worthington; Hayley D McKeen; Lana McClements; Christopher Elliott; Helen O McCarthy; David G Hirst; Tracy Robson
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.752

Review 10.  Novel endogenous angiogenesis inhibitors and their therapeutic potential.

Authors:  Nithya Rao; Yu Fei Lee; Ruowen Ge
Journal:  Acta Pharmacol Sin       Date:  2015-09-14       Impact factor: 6.150

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.